MAXCYTE, Offering Tuesday, November 10, 2026 -0.20 Negative

MaxCyte enters into securities purchase agreement

MaxCyte, Inc. has agreed to a stock purchase agreement with security holders Ohio TopCo LP and Arcline Capital Partners A LP, dated November 9, 2026, for a preliminary estimated purchase price of $110.0 million.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed